Nifty

:

25571.25

Sensex

:

82814.71

116.90 (0.46%)
316.57 (0.38%)

Login

Nifty
Sensex

:
:

25571.25
82814.71

116.90 (0.46%)
316.57 (0.38%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

70/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

4931.70

20-Feb-2026

Open
High
Low
Previous Close

4963
5003.9
4913.1
4991.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

10109
50099643
5993
3701

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

22,589.09
26.46
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

19,887.79
3.34%
5.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.26
0.38
-2.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.51
0.77
-1.76

PAT CAGR (%)

10 Years
5 Years
3 Years

9.67
9.06
7.15

P:E (Median)

8 Years
5 Years
3 Years

34.83
34.66
31.90

P:BV (Average)

8 Years
5 Years
3 Years

6.89
6.78
5.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.51
22.40
21.50

Earnings Forecasts:

(Updated: 21-02-2026)

Description 2024 2025 2026 2027
Adj EPS 167.79 170.94 183.73 205.28
P/E Ratio 29.39 28.85 26.84 24.02
Revenue 2281.35 2504.3 2747.05 3043.8
EBITDA 740.44 888.3 965.02 1076.63
Net Income 767.6 735.6 837.55 934.7
ROA 16.8
P/B Ratio 5.35 4.79 4.46 4.00
ROE 19.65 17.64 16.99 17.3
FCFF 790.5 776.3 598.47 684.24
FCFF Yield 3.87 3.8 2.93 3.35
Net Debt -2692.58 0 0 0
BVPS 921.88 1029.1 1104.75 1234.21

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 645.03 537.99 19.90% 642.34 588.59 9.13% 603.05 562.86 7.14% 591.91 546.63 8.28%
Expenses 416.84 392.00 6.34% 412.41 399.34 3.27% 393.03 385.37 1.99% 364.41 357.20 2.02%
EBITDA 228.19 145.99 56.31% 229.93 189.25 21.50% 210.02 177.49 18.33% 227.50 189.43 20.10%
EBIDTM 35.38% 27.14% 35.80% 32.15% 34.83% 31.53% 38.43% 34.65%
Other Income 38.21 42.76 -10.64% 41.85 43.07 -2.83% 67.17 41.84 60.54% 44.58 75.13 -40.66%
Interest 1.99 1.51 31.79% 2.13 2.10 1.43% 3.25 2.11 54.03% 2.69 6.95 -61.29%
Depreciation 14.26 14.80 -3.65% 14.28 14.99 -4.74% 14.41 14.60 -1.30% 16.40 13.75 19.27%
PBT 191.95 172.44 11.31% 255.37 215.23 18.65% 259.53 202.62 28.09% 425.80 243.86 74.61%
Tax 50.11 44.84 11.75% 66.35 56.88 16.65% 67.78 51.91 30.57% 94.86 65.00 45.94%
PAT 141.84 127.60 11.16% 189.02 158.35 19.37% 191.75 150.71 27.23% 330.94 178.86 85.03%
PATM 21.99% 23.72% 29.43% 26.90% 31.80% 26.78% 55.91% 32.72%
EPS 31.04 27.92 11.17% 41.36 34.65 19.37% 41.96 32.98 27.23% 72.42 39.14 85.03%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,482.33 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50 1,968.51 1,966.26 2,012.34 Net Sales Growth 11.01% 4.02% -9.55% -7.13% 16.64% 4.04% 3.37% 5.74% 0.11% -2.29% Cost Of Goods Sold 866.43 755.56 729.77 802.73 875.65 734.29 741.69 678.48 677.55 711.67 698.85 Gross Profit 1,615.90 1,525.79 1,463.40 1,622.03 1,735.34 1,504.26 1,409.96 1,403.02 1,290.96 1,254.59 1,313.49 GP Margin 65.10% 66.88% 66.73% 66.89% 66.46% 67.20% 65.53% 67.40% 65.58% 63.81% 65.27% Total Expenditure 1,586.69 1,541.03 1,557.85 1,615.81 1,775.05 1,526.15 1,578.93 1,515.87 1,467.87 1,616.13 1,579.46 Power & Fuel Cost - 3.48 3.98 6.51 5.67 5.79 11.04 11.45 12.34 10.34 10.43 % Of Sales - 0.15% 0.18% 0.27% 0.22% 0.26% 0.51% 0.55% 0.63% 0.53% 0.52% Employee Cost - 371.33 347.80 331.68 403.67 361.06 364.51 323.84 314.29 303.89 277.34 % Of Sales - 16.28% 15.86% 13.68% 15.46% 16.13% 16.94% 15.56% 15.97% 15.46% 13.78% Manufacturing Exp. - 105.43 113.97 122.57 132.19 123.71 104.97 131.96 118.74 151.54 153.84 % Of Sales - 4.62% 5.20% 5.05% 5.06% 5.53% 4.88% 6.34% 6.03% 7.71% 7.64% General & Admin Exp. - 142.48 158.53 158.87 162.66 130.80 165.96 182.49 173.38 234.11 207.63 % Of Sales - 6.25% 7.23% 6.55% 6.23% 5.84% 7.71% 8.77% 8.81% 11.91% 10.32% Selling & Distn. Exp. - 117.57 159.43 139.16 148.11 137.87 153.70 152.83 143.35 152.82 168.00 % Of Sales - 5.15% 7.27% 5.74% 5.67% 6.16% 7.14% 7.34% 7.28% 7.77% 8.35% Miscellaneous Exp. - 45.18 44.37 54.29 47.10 32.63 37.06 34.82 28.22 51.76 168.00 % Of Sales - 1.98% 2.02% 2.24% 1.80% 1.46% 1.72% 1.67% 1.43% 2.63% 3.15% EBITDA 895.64 740.32 635.32 808.95 835.94 712.40 572.72 565.63 500.64 350.13 432.88 EBITDA Margin 36.08% 32.45% 28.97% 33.36% 32.02% 31.82% 26.62% 27.17% 25.43% 17.81% 21.51% Other Income 191.81 172.25 180.51 101.05 62.65 81.12 184.02 167.39 114.29 101.16 86.99 Interest 10.06 8.50 15.43 13.48 10.70 15.39 11.01 1.72 0.77 1.96 1.40 Depreciation 59.35 60.79 62.28 105.51 115.00 109.41 103.24 71.39 66.25 62.93 57.93 PBT 1,132.65 843.28 738.12 791.01 772.89 668.72 642.49 659.91 547.91 386.40 460.54 Tax 279.10 248.49 194.74 200.08 160.33 171.11 133.36 230.86 187.84 180.05 165.44 Tax Rate 24.64% 24.46% 26.10% 24.28% 20.74% 25.59% 20.76% 34.98% 34.28% 34.84% 35.17% PAT 853.55 767.60 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 304.98 PAT before Minority Interest 853.55 767.60 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 304.98 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 34.39% 33.65% 25.14% 25.73% 23.46% 22.23% 23.66% 20.61% 18.29% 17.13% 15.16% PAT Growth 38.67% 39.23% -11.64% 1.86% 23.10% -2.26% 18.66% 19.16% 6.92% 10.43% EPS 186.77 167.96 120.64 136.53 134.04 108.89 111.41 93.88 78.79 73.69 66.74

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,217.41 3,595.54 3,207.30 2,864.41 2,393.04 3,395.49 3,011.34 2,683.20 2,418.88 2,163.50 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 Total Reserves 4,171.66 3,549.79 3,161.55 2,818.66 2,347.29 3,349.74 2,965.59 2,637.45 2,373.13 2,117.75 Non-Current Liabilities 54.89 32.74 38.41 136.23 85.06 135.93 36.96 52.32 62.41 66.14 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.50 Long Term Provisions 56.57 32.33 42.76 55.47 55.84 47.87 34.73 37.74 44.85 35.30 Current Liabilities 569.51 546.56 657.35 852.89 774.34 873.36 891.69 954.44 779.67 658.41 Trade Payables 151.60 166.23 217.06 263.94 283.74 426.78 435.92 495.63 388.00 337.92 Other Current Liabilities 143.11 172.80 176.49 345.92 361.47 340.37 294.19 302.29 241.36 181.52 Short Term Borrowings 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 0.00 Short Term Provisions 272.30 205.03 261.30 240.53 126.63 103.71 159.08 154.02 147.81 138.97 Total Liabilities 4,841.81 4,174.84 3,903.06 3,853.53 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 Net Block 723.62 712.71 749.25 840.96 864.74 941.91 853.86 916.60 867.08 924.86 Gross Block 1,418.48 1,355.73 1,352.40 1,345.28 1,278.52 1,277.00 1,100.27 1,094.86 983.27 980.63 Accumulated Depreciation 694.86 643.02 603.15 504.32 413.78 335.09 246.41 178.26 116.19 55.77 Non Current Assets 1,328.96 1,405.28 1,377.97 1,457.05 1,343.96 1,356.53 1,224.63 1,273.24 1,209.65 1,255.58 Capital Work in Progress 7.64 0.40 7.93 1.15 2.76 0.76 0.00 1.04 15.35 3.27 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 541.34 589.78 550.26 549.20 291.62 255.26 225.11 236.25 226.29 225.71 Other Non Current Assets 56.36 102.39 70.53 37.57 155.28 127.65 113.33 85.63 65.82 65.23 Current Assets 3,512.85 2,737.81 2,493.34 2,361.44 1,873.30 3,013.07 2,701.68 2,403.04 2,032.50 1,613.88 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 475.92 433.69 417.70 448.90 435.05 430.59 386.66 297.06 321.90 360.68 Sundry Debtors 193.09 187.61 151.73 142.55 108.77 172.03 171.66 154.80 110.32 142.30 Cash & Bank 2,800.98 2,046.71 1,859.52 1,643.44 1,115.10 2,219.87 1,914.34 1,771.86 1,523.09 1,024.65 Other Current Assets 42.86 21.31 21.79 23.02 214.38 190.58 229.02 179.32 77.19 86.26 Short Term Loans & Adv. 29.12 48.49 42.60 103.53 18.43 25.82 29.80 45.96 52.48 57.20 Net Current Assets 2,943.34 2,191.25 1,835.99 1,508.55 1,098.96 2,139.71 1,809.99 1,448.60 1,252.83 955.47 Total Assets 4,841.81 4,143.09 3,871.31 3,818.49 3,217.26 4,369.60 3,926.31 3,676.28 3,242.15 2,869.46

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 659.75 256.84 355.68 667.08 427.33 323.18 97.81 331.80 328.82 345.48 PBT 1,016.09 746.07 824.01 772.89 668.72 642.49 659.91 547.91 516.83 470.42 Adjustment -256.91 -89.32 -131.26 76.17 54.53 -53.56 -79.47 -32.98 -153.93 -19.53 Changes in Working Capital 56.79 -246.09 -34.49 43.94 -91.78 -52.46 -245.07 10.48 148.91 68.61 Cash after chg. in Working capital 815.97 410.66 658.26 893.00 631.47 536.47 335.37 525.41 511.81 519.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -156.22 -153.82 -302.58 -225.92 -204.14 -213.29 -237.56 -193.61 -182.99 -174.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -71.34 53.70 -36.05 -575.02 -468.84 1,530.32 35.12 -238.31 -249.64 -700.87 Net Fixed Assets -69.99 4.20 -13.90 -65.15 -3.52 -177.49 -4.37 -97.28 -14.72 317.26 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 42.66 Others -1.35 49.50 -22.15 -509.87 -465.32 1,707.81 39.49 -141.03 -234.92 -1,060.79 Cash from Financing Activity -205.34 -235.14 -345.79 -180.51 -1,571.07 -163.52 -109.85 -110.35 -82.59 -61.88 Net Cash Inflow / Outflow 383.07 75.40 -26.16 -88.45 -1,612.58 1,689.98 23.08 -16.86 -3.41 -417.27 Opening Cash & Equivalents 112.00 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40 Closing Cash & Equivalent 495.07 112.00 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 921.84 785.91 701.05 626.10 523.07 742.18 658.22 586.49 528.72 472.92 ROA 17.03% 13.65% 16.09% 17.24% 13.00% 12.20% 11.25% 10.36% 10.95% 11.22% ROE 19.65% 16.21% 20.55% 23.30% 17.19% 15.89% 15.07% 14.11% 14.70% 14.75% ROCE 26.21% 22.37% 27.56% 29.78% 23.62% 20.38% 23.22% 21.49% 22.62% 22.78% Fixed Asset Turnover 1.72 1.71 1.90 2.07 1.75 1.81 1.90 1.91 2.08 1.85 Receivable days 29.10 26.74 20.98 16.89 22.89 29.15 28.62 24.43 22.58 26.35 Inventory Days 69.53 67.09 61.77 59.41 70.57 69.32 59.95 57.05 61.01 65.25 Payable days 76.77 95.85 109.36 114.15 176.59 102.95 115.62 121.93 93.70 92.76 Cash Conversion Cycle 21.86 -2.02 -26.61 -37.84 -83.13 -4.48 -27.05 -40.45 -10.12 -1.16 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 120.54 49.35 62.13 73.23 44.45 59.36 384.67 712.57 264.69 337.93

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

nippon life india trustee ltd

life insurance corporation of india

quant mutual fund

sbi mutual fund

icici prudential pharma healthcare and diaganostic

investor education and protection fund (iepf)

Annual Reports:

News Update:

Pfizer enters into marketing, distribution agreement with Cipla for 4 brands in India
19th Dec 2025, 15:00 PM

The agreement aims to make the company’s medicines widely available across India by combining its well-established portfolio with Cipla’s deep market reach
Read More
Pfizer launches new medication for migraine treatment
17th Nov 2025, 17:24 PM

The company has introduced Rimegepant ODT in India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback